Thomas M. Rinderknecht
Basilea Pharmaceutica Ltd
Dr. Thomas M. Rinderknecht, Vice-Chairman, Swiss citizen, has served as a member of the Board of Directors since 2011. Dr. Rinderknecht is a senior partner at the law firm Badertscher Rechtsanwälte AG, in Zurich and Zug. He currently serves as member of the board and the audit committee of Chocoladefabriken Lindt & Sprüngli AG (starting April 2016); as chairman of the Canyon Pharmaceuticals Group of Companies, Spanset Inter AG, Wollerau, and Caveat Holding AG, Hergiswil; as vice chairman of APR Applied Pharma Research SA, Balerna, and the Marquard Media Group. He also serves as a member of the board of InSphero AG, Schlieren; Twin Dolphins AG, Zug; ADC Therapeutics SA, Epalinges (starting May 2016); Hotel de la Paix SA, Geneva (starting April 2016); the jointly controlled Badertscher Rechtsanwälte AG and Veritas Trust AG /Fundmaster AG Family Office Companies; and the NorseSatCom/iJet Group of Companies. Until February 2016 he served as chairman of Vecap Venture Capital Partners AG, Stansstad, and of FLH Brands AG, Zug. Dr. Rinderknecht holds a Ph.D. in law from the University of Zurich and is admitted to the Bar in Zurich.